The prevalence and burden of Rome IV bowel disorders of gut brain interaction in patients with non-alcoholic fatty liver disease: a cross-sectional study (2023)
Attributed to:
Interrogating ITGA11 signalling in rodent and human for targeted anti-fibrotic therapy in liver fibrosis.
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1038/s41598-023-35774-5
PubMed Identifier: 37253969
Publication URI: http://europepmc.org/abstract/MED/37253969
Type: Journal Article/Review
Parent Publication: Scientific Reports
Issue: 1
ISSN: 2045-2322